News

AstraZeneca’s Trixeo gets EU approval for asthma maintenance treatment

Sep 23, 2026 | News, Regulatory

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of exacerbation history

CSL Seqirus announces strengthened vaccine partnership with UK government

Sep 22, 2026 | News, Healthcare

The partnership introduces a world-first flu vaccine and extends the health security pandemic agreement

Galimedix establishes Alzheimer’s Disease Scientific Advisory Board

Sep 22, 2026 | News, Research

The Board will advise Galimedix on scientific and clinical strategy

Novartis’ Cosentyx gets positive CHMP opinion for polymyalgia rheumatica

Sep 21, 2026 | News, Regulatory

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica

Cancer researchers investigate why smouldering myeloma progresses

Sep 18, 2026 | News, Research

Around 6,500 people are diagnosed with myeloma in the UK each year

Roche and Dualitas Therapeutics announce research collaboration worth up to $1bn

Sep 17, 2026 | News, Research

The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases

Gilead and PAHO announce milestone partnership to accelerate access to HIV pre-exposure treatment

Sep 16, 2026 | News, Healthcare

The agreement will improve access to twice-yearly Lenacapavir across Latin America and the Caribbean

J&J’s Darzalex combination treatment for untreated multiple myeloma recommended by NICE

Sep 15, 2026 | News, Regulatory

Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer

AstraZeneca’s Tagrisso shows eight-year landmark survival in early-stage EGFR-mutated lung cancer

Sep 14, 2026 | News, Research

The results from a global phase 3 trial show the longest survival data ever reported in this setting

Moderna’s updated COVID-19 mRNA vaccine approved by MHRA

Sep 13, 2026 | News, Regulatory

The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme

Phase 3 results announced for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer

Sep 11, 2026 | News, Research

Around 195,000 people globally will be treated for this form of lung cancer in 2026

Roche’s Enspryng gets FDA Priority Review for autoimmune disease with no approved treatments

Sep 10, 2026 | News, Regulatory

MOGAD, a rare disease of the central nervous system, can attack optic nerves, the spinal cord and the brain

AstraZeneca’s Trixeo gets EU approval for asthma maintenance treatment

CSL Seqirus announces strengthened vaccine partnership with UK government

Galimedix establishes Alzheimer’s Disease Scientific Advisory Board

Novartis’ Cosentyx gets positive CHMP opinion for polymyalgia rheumatica

Cancer researchers investigate why smouldering myeloma progresses

Roche and Dualitas Therapeutics announce research collaboration worth up to $1bn

Gilead and PAHO announce milestone partnership to accelerate access to HIV pre-exposure treatment

J&J’s Darzalex combination treatment for untreated multiple myeloma recommended by NICE

AstraZeneca’s Tagrisso shows eight-year landmark survival in early-stage EGFR-mutated lung cancer

Moderna’s updated COVID-19 mRNA vaccine approved by MHRA

Phase 3 results announced for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer

Roche’s Enspryng gets FDA Priority Review for autoimmune disease with no approved treatments

Latest content

Latest intelligence

Quick links